Aishah Ali

About Aishah Ali

My current role is in drug development as the Director of Global Late Clinical Development at Teva. Former Senior Physician and clinical reviewer at the FDA in the Division of Pulmonology, Allergy, and Critical Care. I have experience in a broad range of drug and device products including small molecules, biologics, inhaled therapeutics,and propellants. My commitment to advancing patient care is motivated by innovation and access. My regulatory experience encompasses the drug development process from the Pre-Investigational New Drug (Pre-IND) stage through the post-marketing period, including extensive experience in clinical trial design (including pediatrics and rare diseases), data analysis/statistical interpretation, and pharmacovigilance. I also have experience in FDA guidance development, review of clinical outcome assessment (COA) qualification programs, advertisement review, and presenting at clinical trial workshops.Views expressed here are my own and do not reflect my employer.

Experience

1. Director, Global Late Clinical Development

   Teva Pharmaceuticals

   Aug 2025 — Present

   Therapeutic Area: Respiratory and Atopic Diseases- Provide clinical and regulatory expertise - Lead late respiratory clinical programs - Advise on early clinical programs - Work closely with cross functional teams in Teva\'s Pivot to Growth Innovative Strategy

Education

• The Johns Hopkins University School of Medicine

  Allergy and Clinical Immunology Fellow

  2015 — 2017

• Jefferson Health

  Internal Medicine Residency Program

  2012 — 2015

• Michigan State University

  Bachelor of Science - BS, Psychology

  2003 — 2007

• Michigan State University College of Human Medicine

  Doctor of Medicine - MD

  2008 — 2012